242 related articles for article (PubMed ID: 3408455)
1. Present status of standardization in coagulation assays for control of oral anticoagulation.
Dati F; Becker U
Behring Inst Mitt; 1988 Apr; (82):309-24. PubMed ID: 3408455
[TBL] [Abstract][Full Text] [Related]
2. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
3. [Determination of thromboplastin time with a new standardized thromboplastin from human placenta: results of a cooperative study].
Barthels M; Bruhn HD; Duckert F; Meyer JG; Dati F; Fuhge P
J Clin Chem Clin Biochem; 1987 Apr; 25(4):267-80. PubMed ID: 3625130
[TBL] [Abstract][Full Text] [Related]
4. [Standardization of the thromboplastin time determination].
Dati F
Z Med Lab Diagn; 1990; 31(4):211-24. PubMed ID: 2382469
[TBL] [Abstract][Full Text] [Related]
5. Implications of use of low international sensitivity index thromboplastins in prothrombin time testing.
Ts'ao C; Swedlund J; Neofotistos D
Arch Pathol Lab Med; 1994 Dec; 118(12):1183-7. PubMed ID: 7979911
[TBL] [Abstract][Full Text] [Related]
6. Standardization of prothrombin time for laboratory control of oral anticoagulant therapy.
Kitchen S; Preston FE
Semin Thromb Hemost; 1999; 25(1):17-25. PubMed ID: 10327216
[TBL] [Abstract][Full Text] [Related]
7. International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
Thromb Haemost; 1985 Feb; 53(1):155-6. PubMed ID: 3992515
[No Abstract] [Full Text] [Related]
8. [Prothrombin time and its standardization].
Kagawa K
Rinsho Byori; 2002 Aug; 50(8):779-85. PubMed ID: 12373814
[TBL] [Abstract][Full Text] [Related]
9. [Control of oral anticoagulation. Current concepts].
Aguilar CA; Hurtado Monroy R; Gaspar Hernández J
Rev Invest Clin; 1989; 41(4):371-4. PubMed ID: 2698502
[TBL] [Abstract][Full Text] [Related]
10. Multicenter evaluation of a chromogenic substrate method for photometric determination of prothrombin time.
Dati F; Barthels M; Conard J; Flückiger J; Girolami A; Hänseler E; Huber J; Keller F; Kolde HJ; Müller-Berghaus G
Thromb Haemost; 1987 Oct; 58(3):856-65. PubMed ID: 3433249
[TBL] [Abstract][Full Text] [Related]
11. Oral anticoagulant therapy control: evidence that INR expression improves the inter-laboratory comparability of results--the Bologna oral anticoagulant control exercise.
Palareti G; Coccheri S; Poggi M; Bonetti M; Cervi V; Mazzuca A; Savoia M; Veri L; Fiori F; Gaspari G
Thromb Haemost; 1987 Oct; 58(3):905-10. PubMed ID: 3433253
[TBL] [Abstract][Full Text] [Related]
12. Results of a multicenter study assessing the status of standardization of a recombinant thromboplastin for the control of oral anticoagulant therapy.
Tripodi A; Chantarangkul V; Braga M; Poller L; ten Cate JW; van den Besselaar AM; Mannucci PM
Thromb Haemost; 1994 Aug; 72(2):261-7. PubMed ID: 7831663
[TBL] [Abstract][Full Text] [Related]
13. Laboratory monitoring of oral anticoagulant therapy.
Poller L; Samama M
Clin Lab Med; 1994 Dec; 14(4):813-23. PubMed ID: 7874873
[TBL] [Abstract][Full Text] [Related]
14. [Standardization problems in the monitoring of oral anticoagulants by Quick's thromboplastin time: an attempt to determine the state of the problem in Switzerland].
Marti P; Beck EA
Schweiz Med Wochenschr; 1983 Oct; 113(43):1593-7. PubMed ID: 6648436
[TBL] [Abstract][Full Text] [Related]
15. Long-term French experience in INR standardization by a procedure using plasma calibrants.
Houbouyan LL; Goguel AF
Am J Clin Pathol; 1997 Jul; 108(1):83-9. PubMed ID: 9208983
[TBL] [Abstract][Full Text] [Related]
16. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
[TBL] [Abstract][Full Text] [Related]
17. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
18. [Monitoring of coagulation status in the physician's laboratory].
Marbet GA
Ther Umsch; 1995 May; 52(5):343-9. PubMed ID: 7770821
[TBL] [Abstract][Full Text] [Related]
19. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
van den Besselaar AM
J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
[TBL] [Abstract][Full Text] [Related]
20. [Suggestions and propositions to resolve some issues for standardization of prothrombin time and activated partial thromboplastin time].
Kagawa K; Fukutake K
Rinsho Byori; 1999 May; 47(5):431-7. PubMed ID: 10375964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]